[PROVISIONAL] Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma

Abstract Mucolipidosis II and III (ML II and III) alpha/beta and ML III gamma are lysosomal diseases caused by GlcNAc-1-phosphotransferase deficiency. Previous data indicate that MLII patients have a functionally impaired immune system that contributes to the high predisposition to infections. We ev...

Full description

Bibliographic Details
Main Authors: Fernanda Sperb-Ludwig, Taciane Alegra, Renata Voltolini Velho, Nataniel Ludwig, Marina Siebert, Mariana Jobim, Filippo Vairo, Ida V. D. Schwartz
Format: Article
Language:English
Published: Sociedade Brasileira de Genética
Series:Genetics and Molecular Biology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572019005022104&lng=en&tlng=en
Description
Summary:Abstract Mucolipidosis II and III (ML II and III) alpha/beta and ML III gamma are lysosomal diseases caused by GlcNAc-1-phosphotransferase deficiency. Previous data indicate that MLII patients have a functionally impaired immune system that contributes to the high predisposition to infections. We evaluated the immunological phenotype of three Brazilian patients with ML III gamma. Our data suggest that the residual activity of the enzyme in patients with ML III gamma is enough to allow the targeting lysosomal enzymes required for B-cell functions maintenance. Herein, we evaluate the immunological phenotype of Brazilian patients with ML III gamma.
ISSN:1678-4685